1. EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy
   James J. Kang et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
2. Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research
   Zhixiang Wang, 2016, International Journal of Molecular Sciences CrossRef
3. Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation
   Masami Nozaki et al, 2019, Cancers CrossRef
4. Multiple post-translational modifications ensure EGFR functionality: Potential therapeutic targets to overcome its drug-resistance mutations
   Qiangqiang He et al, 2023, Cytokine & Growth Factor Reviews CrossRef
5. The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion
   Emily Cheng et al, 2015, Molecular Cancer Research CrossRef
6. N‐glycosylated GPNMB ligand independently activates mutated EGFR signaling and promotes metastasis in NSCLC
   Chia‐Li Han et al, 2021, Cancer Science CrossRef
7. Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells
   Jen-Chih Tseng et al, 2023, Phytomedicine CrossRef
8. IL-8 secreted by tumor associated macrophages contribute to lapatinib resistance in HER2-positive locally advanced breast cancer via activation of Src/STAT3/ERK1/2-mediated EGFR signaling
   Shaza Ahmed et al, 2021, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
9. The Cross-Talk Between EGFR and E-Cadherin
   Miguel Ramírez Moreno et al, 2022, Frontiers in Cell and Developmental Biology CrossRef